Insulet collaborates with Samsung to deliver Galaxy smartphone-controlled insulin pump delivery system
Insulet, a in tubeless insulin pump technology company with its Omnipod Insulin Management System (Omnipod System), announced it is collaborating with Samsung, for a Samsung Galaxy smartphone-controlled Omnipod System. Once approved, the system will be the first device providing consumers the ability to use their personal Galaxy smartphone to securely control their insulin pump therapy.
The Samsung Knox mobile security platform is built into all Samsung mobile devices and is comprised of overlapping defense and security mechanisms to protect against cybersecurity risks. Insulet’s FDA-cleared Omnipod DASH Insulin Management System (Omnipod DASH System) has been designed as an app on a locked-down mobile phone incorporating state-of-the-art security features. The Knox platform complements the Omnipod DASH System security features by verifying the integrity of the Samsung mobile device through a series of security checks starting from the hardware level and extending through the operating system, creating a highly-secure platform. This will allow users to securely operate their Omnipod System from their smartphone.
